Producto
Loading
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Producto
Producto
Producto
Producto
VitaPCR™ Influenza/SARS-CoV-2 (Flu/SC2) Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.
Producto
VitaPCR™ Influenza/SARS-CoV-2 Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.
Producto
VitaPCR™ SARS-CoV-2 Gen 2 Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.
Producto
VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.
Artículo
Research record from Intern Med, 2026-10-29. PMID 42951580.
Pruebas
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Pruebas
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
Pruebas
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Pruebas
A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.